AsiaNet Daily Summary - Press Releases for Wednesday, October 25, 2006

Press Releases »

SYDNEY--25 Oct--AsiaNet/InfoQuest


INFORMATION MANAGEMENT...
MELBOURNE: Aconex will provide its online information management service to
Ocean Park Corporation's HK$5.55 billion (US$715 million) Ocean Park Master
Redevelopment Project in Hong Kong.
www.aconex.com

STENT SAFE...
NATICK, Mass., and WASHINGTON: Boston Scientific Corporation Tuesday
announced that an independent meta-analysis of more than 3,500 patients from
five clinical trials, conducted by the Cardiovascular Research Foundation,
confirmed the company's own analysis that the TAXUS paclitaxel-eluting coronary
stent is safe and effective.
http://www.bostonscientific.com

TENTH YEAR...
SYDNEY, Australia: Founded in 1996 by chief executive officer Derek Mercer,
Vurv Technology (formerly Recruitmax) Tuesday announced that this month marks
the company's tenth year in business.
http://www.vurv.com
http://ten.vurv.com

GOLD INDEX...
TORONTO: TSX Group welcomes Standard and Poor's recently announced change to
the methodology of the S&P/TSX Capped Gold Index.
www.tsx.com

FANNIE MAE...
WASHINGTON, D.C.: Fannie Mae will redeem the principal amount of one
securities issue valued at US$50 million on November 3, 2006 at a redemption
price equal to 100 percent of the principal amount redeemed plus accrued
interest.
http://www.fanniemae.com

PROJECT COMPLETED...
SYDNEY: EvoGenix Limited Tuesday reported that it had completed the first
project in its collaboration with pharmaceutical company GlaxoSmithKline (GSK).

CLINICAL TRIAL...
MELBOURNE: Starpharma Holdings Limited Tuesday announced that the U.S. site
for the clinical trial of SPL7013 gel (VivaGel
) for prevention of genital herpes has opened for recruitment of volunteers.
www.starpharma.com

CVRD ACQUIRES...
RIO DE JANEIRO, Brazil: Companhia Vale do Rio Doce (CVRD) Tuesday announced
that 174,623,019 common shares of Inco Limited (Inco) including shares
deposited by guaranteed delivery, representing 75.66% of the Inco common shares
outstanding on a fully-diluted basis, were deposited to the offer to acquire
all of the outstanding common shares of Inco for C$86.00 in cash per Inco
common share as at the expiry time of the offer, midnight (Toronto time) on
October 23, 2006.
http://www.cvrd.com.br

DRUG RESULTS...
LAVAL: REPLICor Inc., a biopharmaceutical company focused on discovering and
developing drugs to treat severe medical conditions, has announced that its
first-in-class drugs, REP 9 and REP 9C, showed potent activity against the
hepatitis C virus (HCV).
www.replicor.com

SCREENING SERVICE...
MANCHESTER: Cyprotex Tuesday announced the launch of a new screening service
to add to their range of permeability assays.
http://www.cyprotex.com

PSORIASIS FOCUS...
NEW YORK: World Psoriasis Day will have a more poignant focus this year as
the International Psoriasis Council (IPC) issues a 'call to action' to medical
experts to elevate psoriasis on the public health agenda by undertaking a more
thorough therapeutic approach.

ACCESS SOLUTION...
NEW DELHI, India: RADWIN, a leading provider of advanced wireless broadband
solutions, Tuesday officially announced the commercial availability of its new
WinLink 1000 Access solution, which provides high-quality, low cost Ethernet
connectivity at the most competitive price in the market -- starting from just
49,600 INR per link.
http://www.radwin.com

NEW APPOINTMENT...
TOKYO: Tele Atlas, a leading global provider of digital maps and dynamic
content for navigation and location based solutions, Tuesday announced the
appointment of Shinya Banno as Managing Director of Tele Atlas Japan.
http://www.teleatlas.com

(AsiaNet is a consortium of leading news agencies distributing unedited,
translated news releases for worldwide clients. Visit www.asianetnews.net for
full-text versions.)

ข่าวBoston Scientific+the companyวันนี้

เมดพาร์ค จัดสัมมนาวิชาการ Cardiac Arrhythmia Conference : Advances in Diagnosis and Management of Cardiac Arrhythmias

เมื่อวันศุกร์ที่ 28 มีนาคม 2568 โรงพยาบาลเมดพาร์ค ร่วมกับ Boston Scientific จัดกิจกรรมสัมมนาวิชาการ Cardiac Arrhythmia Conference ในหัวข้อ Advances in Diagnosis and Management of Cardiac Arrhythmias โดยมีอาจารย์แพทย์ผู้ทรงคุณวุฒิด้านสรีระวิทยาไฟฟ้าหัวใจ ที่มีชื่อเสียงทั้งในประเทศไทยและระดับนานาชาติ ร่วมเป็นวิทยากรบรรยายให้ความรู้แก่บุคลากรทางการแพทย์และประชาชนทั่วไปที่สนใจโดยไม่มีค่าใช้จ่าย ณ ห้องประชุม เดอะ ฟอรัม ชั้น M โดยมี ศ. นพ.สิน อนุราษฎร์ ผู้อำนวยการโรงพยาบาล และประธานเจ้าหน้าที่บริหาร

Boston Scientific ได้รับการรับรอง CE Mark สำหรับกล้องส่องตรวจหลอดลมแบบใช้ครั้งเดียว EXALT(TM) Model B

บริษัทเตรียมวางจำหน่ายในบางตลาดของยุโรป เริ่มมิถุนายนนี้ Boston Scientific Corporation (NYSE: BSX) ประกาศได้รับการรับรอง CE Mark สำหรับกล้องส่องตรวจหลอดลมแบบใช้ครั้งเดียว EXALT(TM) Model B ซึ่ง...

Boston Scientific Completes CE Mark for EXALT(TM) Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT(TM) Model B Single-Use Bronchoscope, a single-use device...

Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement

- Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart...

Joining Forces to Tackle Global Stroke Risk

The AF Association announces a collaboration with Boston Scientific Corporation, a global leader in innovative medical technology, to improve awareness of the most common heart rhythm disorder in the world, atrial fibrillation (AF). More than 71 million...

The World Stroke Organization and Boston Scientific Join Forces to Bolster Awareness and Advocacy Efforts

The World Stroke Organization will team with global medical technology leader Boston Scientific Corporation (NYSE:BSX), to further raise awareness and take action in the worldwide fight against...

บอสตัน ไซแอนทิฟิค จัดตั้งองค์กรใหม่ประจำภูมิภาคเอเชียแปซิฟิก

บอสตัน ไซแอนทิฟิค คอร์ปอเรชั่น (Boston Scientific Corporation) (NYSE: BSX) ประกาศจัดตั้งองค์กรใหม่ประจำภูมิภาคเอเชียแปซิฟิก ซึ่งประกอบไปด้วยออสเตรเลีย นิวซีแลนด์ จีน ฮ่องกง อินเดีย ญี่ปุ่น เกาหลีใต้ เอเชียตะวันออกเฉียงใต้ ไต้หวัน และตุรกี...

Boston Scientific Announces New Asia-Pacific Organization

Boston Scientific Corporation (NYSE: BSX) announces the creation of its Asia-Pacific regional organization that includes Australia, New Zealand, China, Hong Kong, India, Japan, South Korea, South East Asia, Taiwan and Turkey. The Company...

Boston Scientific Receives CE Mark Approval for New Apex(TM) PTCA Dilatation Catheters

- New Design Offers Greater Flexibility in the Management of Patients With Complex Atherosclerosis Boston Scientific Corporation (NYSE: BSX) announced today that the Apex(TM) Monorail and Over-The-Wire (OTW) PTCA...